PRIME MEDICA LIMITED
Get an alert when PRIME MEDICA LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-03 (in 6mo)
Last made up 2025-10-20
Watchouts
None on the register
Cash
£147K
-83.6% lowest in 5 filed years
Net assets
£5M
-5% vs 2023
Employees
287
-4% vs 2023
Profit before tax
£447K
-48.8% lowest in 5 filed years
Net assets
5-year trend · vs Industrials median
Accounts
5-year trend · latest reflected 2024-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Turnover | £8,769,713 | £7,607,834 | — | £11,906,613 | £12,276,547 | |
| Operating profit | £1,034,609 | £1,081,222 | — | £874,568 | £447,194 | |
| Profit before tax | £1,031,842 | £1,089,298 | £982,941 | £874,208 | £447,194 | |
| Net profit | £824,004 | £873,725 | £798,882 | £656,931 | £325,449 | |
| Cash | £978,114 | £496,215 | £627,821 | £893,707 | £146,946 | |
| Total assets less current liabilities | £3,239,626 | £4,132,868 | £4,946,462 | £4,945,102 | £4,680,998 | |
| Net assets | £3,201,675 | £4,075,400 | £4,874,282 | £4,901,213 | £4,655,942 | |
| Equity | £3,201,675 | £4,075,400 | £4,874,282 | £4,901,213 | £4,655,942 | |
| Average employees | 177 | 231 | 260 | 299 | 287 | |
| Wages | £8,634,412 | £11,049,177 | — | £13,410,483 | £14,903,068 | |
| Directors' remuneration | £336,880 | £101,328 | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+3.1%
£11,906,613 £12,276,547
highest in 4 filed years
-
Cash
-83.6%
£893,707 £146,946
lowest in 5 filed years
-
Net assets
-5%
£4,901,213 £4,655,942
-
Employees
-4%
299 287
-
Operating profit
-48.9%
£874,568 £447,194
lowest in 4 filed years
-
Profit before tax
-48.8%
£874,208 £447,194
lowest in 5 filed years
-
Wages
+11.1%
£13,410,483 £14,903,068
highest in 4 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Operating margin | 11.8% | 14.2% | — | 7.3% | 3.6% | |
| Net margin | 9.4% | 11.5% | — | 5.5% | 2.7% | |
| Return on capital employed | 31.9% | 26.2% | — | 17.7% | 9.6% | |
| Gearing (liabilities / total assets) | — | — | — | 64.7% | 73.3% | |
| Current ratio | — | — | — | 1.53x | 1.35x | |
| Interest cover | 373.91x | 2111.76x | — | 2429.36x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- PRIME MEDICA LIMITED 1997-11-13 → present
- GOINGSIMPLY LIMITED 1997-10-20 → 1997-11-13
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Azets Audit Services
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company maintained strong cash reserves throughout 2023 and continues to benefit from additional support originally provided by HSBC in 2022 as it continues its next stage of its growth strategy, in line with its VOS 2026-2030 growth strategy. The Company considers that it has adequate short term cashflows and financing facilities in place to continue to trade and meet its obligations to pay debts as they fall cue.”
Significant events
- “Prime Medica Ltd's turnover increased by 3.1% in 2024, as a result of business restructuring and reallocation of business within the Group.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
1 active · 5 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| PETERSON, Graeme Edward, Dr | Director | 1997-11-03 | Jun 1958 | British |
Show 5 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| SIMPSON, Raquel | Secretary | 1997-11-03 | 2021-04-21 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 1997-10-20 | 1997-11-03 |
| JENKINS, Simon David | Director | 2021-09-28 | 2025-04-30 |
| TOWNSEND, Peter Joseph | Director | 2017-03-16 | 2018-01-26 |
| INSTANT COMPANIES LIMITED | Corporate Nominee Director | 1997-10-20 | 1997-11-03 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Prime Global Medical Communications Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors, significant-influence-or-control-as-firm | 2016-10-01 | Ceased 2016-10-01 |
| Prime Global Medical Communications Ltd. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 93 total filings
Material constitutional events — rename, articles re-file, resolution
- 2021-06-15 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-23 | AA | accounts | Accounts with accounts type full | |
| 2025-10-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-05-01 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-09 | AA | accounts | Accounts with accounts type full | |
| 2023-10-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-02 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-10-02 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2023-07-07 | AA | accounts | Accounts with accounts type full | |
| 2022-11-18 | AUD | auditors | Auditors resignation company | |
| 2022-10-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-16 | AA | accounts | Accounts with accounts type full | |
| 2021-10-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-30 | AA | accounts | Accounts with accounts type full | |
| 2021-09-28 | AP01 | officers | Appoint person director company with name date | |
| 2021-07-09 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2021-06-15 | RESOLUTIONS | resolution | Resolution | |
| 2021-06-04 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2021-05-12 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2021-04-21 | TM02 | officers | Termination secretary company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.